Survival nomogram for patients with de novo metastatic breast cancer based on the SEER database and an external validation cohort

Background: On average, 5–10% of patients are diagnosed with metastatic breast cancer (MBC) at the initial diagnosis. This study aimed to develop a nomogram to predict the overall survival (OS) in these patients. Methods: The nomogram was based on a retrospective study of 9435 patients with de novo...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Lizhi Ning, Yaobang Liu, Yujin Hou, Miaozhou Wang, Mingqiang Shi, Zhen Liu, Jiuda Zhao, Xinlan Liu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2023-10-01
Sarja:	Cancer Pathogenesis and Therapy
Aiheet:	De novo metastatic breast cancer Overall survival SEER Nomogram
Linkit:	http://www.sciencedirect.com/science/article/pii/S2949713223000472
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!